Position in BMEA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$188,933
-$130,783 QoQ
Shares Held
128,526
-38.5% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 61 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMEA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. BMEA ranks #324 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in BMEA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $188,933 | 128,526 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $319,716 | 208,965 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $259,115 | 208,965 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $379,010 | 187,629 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $246,466 | 136,926 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $633,854 | 297,585 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,251,880 | 322,650 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,135,443 | 310,440 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $953,783 | 211,952 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,235,837 | 216,444 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,228,841 | 222,372 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,547,731 | 185,155 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,974,880 | 181,088 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $967,697 | 31,206 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $247,428 | 29,351 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $287,051 | 29,351 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $204,186 | 17,044 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $742,339 | 166,444 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,295,911 | 173,948 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $985,214 | 82,307 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,398,530 | 89,592 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||